Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

Name: Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
License: Public Domain

Candel Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

prostate cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152419
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.